Maxim Group analyst Jason McCarthy maintained a Buy rating on Oncolytics Biotech (ONCY – Research Report) yesterday and set a price ...
It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback